<abstract xmlns="http://www.w3.org/1999/xhtml"><p>The portal vein thrombosis (PVT) is one of the most frequent vascular diseases of the liver, with a high rate of morbidity and mortality. The most common causes of the PVT are hepatic cirrhosis, hepatobiliary neoplasms, inflammatory and infectious abdominal diseases, and myeloproliferative syndromes.(1,2) The natural progress of the PVT has as a result portal hypertension which leads to splenomegaly and the formation of portosystemic collateral vessels, as well as gastroesophageal, duodenal and jejunal varices. Ultrasonography, especially Doppler ultrasound, is the most widely used imaging method to asses, supervise and diagnose PVT in patients with hepatopathies. The purpose of acute PVT treatment is to re-permeabilize the obstructed vessels; the endoscopic ligature of the varices in the eventuality of their rupture is safe and extremely efficient in chronic PVT. To conclude, PVT is the most common hepatic vascular disorder, and its prevalence has increased particularly among the patients with chronic hepatopathies.(3)</p></abstract>

The portal vein thrombosis (PVT) is one of the most frequent vascular diseases of the liver, with a high rate of morbidity and mortality. The most common causes of the PVT are hepatic cirrhosis, hepatobiliary neoplasms, inflammatory and infectious abdominal diseases, and myeloproliferative syndromes.(1,2) The natural progress of the PVT has as a result portal hypertension which leads to splenomegaly and the formation of portosystemic collateral vessels, as well as gastroesophageal, duodenal and jejunal varices. Ultrasonography, especially Doppler ultrasound, is the most widely used imaging method to asses, supervise and diagnose PVT in patients with hepatopathies. The purpose of acute PVT treatment is to re-permeabilize the obstructed vessels; the endoscopic ligature of the varices in the eventuality of their rupture is safe and extremely efficient in chronic PVT. To conclude, PVT is the most common hepatic vascular disorder, and its prevalence has increased particularly among the patients with chronic hepatopathies.(3)

Risk Factors Regarding Portal Vein Thrombosis in Chronic Liver Disease

Acta Medica Transilvanica

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

{"article-title":"Risk Factors Regarding Portal Vein Thrombosis in Chronic Liver Disease"}

The portal vein thrombosis (PVT) is one of the most frequent vascular diseases of the liver, with a high rate of morbidity and mortality. The most common...

Risk Factors Regarding Portal Vein Thrombosis in Chronic Liver Disease

Publié en ligne: 29 janv. 2021

Pages: 38 - 41

Reçu: 09 sept. 2020

Accepté: 02 déc. 2020

DOI: https://doi.org/10.2478/amtsb-2020-0068

Mots clés
cirrhosis, portal vein thrombosis, hepatocellular carcinoma

© 2020 Liliana Vecerzan et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Risk Factors Regarding Portal Vein Thrombosis in Chronic Liver Disease

Publié en ligne: 29 janv. 2021

Pages: 38 - 41

Reçu: 09 sept. 2020

Accepté: 02 déc. 2020

DOI: https://doi.org/10.2478/amtsb-2020-0068

Mots cléscirrhosis, portal vein thrombosis, hepatocellular carcinoma

© 2020 Liliana Vecerzan et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Mots clés
cirrhosis, portal vein thrombosis, hepatocellular carcinoma